IL129351A0 - Hiv and cancer treatment - Google Patents
Hiv and cancer treatmentInfo
- Publication number
- IL129351A0 IL129351A0 IL12935197A IL12935197A IL129351A0 IL 129351 A0 IL129351 A0 IL 129351A0 IL 12935197 A IL12935197 A IL 12935197A IL 12935197 A IL12935197 A IL 12935197A IL 129351 A0 IL129351 A0 IL 129351A0
- Authority
- IL
- Israel
- Prior art keywords
- hiv
- cancer treatment
- cancer
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4672697P | 1997-05-16 | 1997-05-16 | |
| PCT/US1997/021564 WO1998051303A1 (en) | 1997-05-16 | 1997-11-26 | Hiv and cancer treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL129351A0 true IL129351A0 (en) | 2000-02-17 |
Family
ID=21945046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12935197A IL129351A0 (en) | 1997-05-16 | 1997-11-26 | Hiv and cancer treatment |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0954309A1 (en) |
| JP (1) | JP2000510156A (en) |
| KR (1) | KR20000049064A (en) |
| CN (1) | CN1254281A (en) |
| AR (1) | AR009968A1 (en) |
| AU (1) | AU7402998A (en) |
| BR (1) | BR9712981A (en) |
| CA (1) | CA2268848A1 (en) |
| CO (1) | CO5070657A1 (en) |
| CZ (1) | CZ124999A3 (en) |
| HU (1) | HUP9904092A3 (en) |
| IL (1) | IL129351A0 (en) |
| NO (1) | NO991701L (en) |
| PE (1) | PE11499A1 (en) |
| PL (1) | PL335160A1 (en) |
| SK (1) | SK46999A3 (en) |
| TR (1) | TR199901530T2 (en) |
| WO (1) | WO1998051303A1 (en) |
| ZA (1) | ZA979095B (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
| US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
| US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
| US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
| US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
| US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
| US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
| US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
| CA2362047A1 (en) * | 1999-02-26 | 2000-08-31 | Larry Helson | Treatment regimen for prostate cancer, initiated after androgen ablative therapy has started |
| WO2000050022A2 (en) * | 1999-02-26 | 2000-08-31 | Napro Biotherapeutics, Inc. | Treatment regimen for hormone-sensitive cancers |
| US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
| WO2002015912A1 (en) * | 2000-08-25 | 2002-02-28 | Beth Israel Deaconess Medical Center | Compounds and methods for inhibiting neuronal cell death |
| US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6407105B1 (en) * | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| AU2001292796B2 (en) * | 2000-09-26 | 2005-12-22 | Uaf Technologies And Research Llc | Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
| US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| WO2002041891A2 (en) * | 2000-11-01 | 2002-05-30 | The Procter & Gamble Company | Hiv treatment with benzimidazoles |
| JP2004115397A (en) * | 2002-09-25 | 2004-04-15 | Fuji Photo Film Co Ltd | Liposome comprising therapeutic agent for vascular disease |
| EP1830847B1 (en) | 2004-12-06 | 2014-11-19 | Pitney Pharmaceuticals Pty Limited | Treatment for cancer |
| AU2005313839B2 (en) * | 2004-12-06 | 2010-03-11 | Pitney Pharmaceuticals Pty Limited | Treatment for cancer |
| US7727967B2 (en) * | 2006-02-24 | 2010-06-01 | Boise State University | Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines |
| WO2009043093A1 (en) * | 2007-10-04 | 2009-04-09 | Newsouth Innovations Pty Limited | Hif inhibition |
| CN101643729B (en) * | 2008-08-07 | 2011-12-28 | 复旦大学 | Nucleic acid molecule NRN1SR22 and application thereof in preparation of anticancer medicaments |
| WO2015140792A1 (en) * | 2014-03-16 | 2015-09-24 | Hadasit Medical Research Services And Development Ltd. | Type iii deiodinase inhibitors and uses thereof |
| CN105418711A (en) * | 2015-11-06 | 2016-03-23 | 山东大学 | Application of alpha-L-rhamnosidase to preparing hydroxycarbamide and glycoside derivatives |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1090186C (en) * | 1993-03-31 | 2002-09-04 | 麦克公司 | HIV protease inhibitors in pharmaceutical combinations for the treatment of AIDS |
| AU714056B2 (en) * | 1995-04-12 | 1999-12-16 | Uaf Technologies And Research Llc | A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers |
| US5665713A (en) * | 1995-04-12 | 1997-09-09 | Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US5656615A (en) * | 1995-04-12 | 1997-08-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals |
| IL123095A0 (en) * | 1995-08-04 | 1998-09-24 | Procter & Gamble | Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers |
-
1997
- 1997-10-09 PE PE1997000894A patent/PE11499A1/en not_active Application Discontinuation
- 1997-10-10 ZA ZA9709095A patent/ZA979095B/en unknown
- 1997-10-10 AR ARP970104697A patent/AR009968A1/en unknown
- 1997-11-07 CO CO97065469A patent/CO5070657A1/en unknown
- 1997-11-26 WO PCT/US1997/021564 patent/WO1998051303A1/en not_active Application Discontinuation
- 1997-11-26 CZ CZ991249A patent/CZ124999A3/en unknown
- 1997-11-26 TR TR1999/01530T patent/TR199901530T2/en unknown
- 1997-11-26 BR BR9712981-0A patent/BR9712981A/en unknown
- 1997-11-26 AU AU74029/98A patent/AU7402998A/en not_active Abandoned
- 1997-11-26 EP EP97949599A patent/EP0954309A1/en not_active Withdrawn
- 1997-11-26 CN CN97182189A patent/CN1254281A/en active Pending
- 1997-11-26 KR KR1019990703137A patent/KR20000049064A/en not_active Application Discontinuation
- 1997-11-26 SK SK469-99A patent/SK46999A3/en unknown
- 1997-11-26 CA CA002268848A patent/CA2268848A1/en not_active Abandoned
- 1997-11-26 PL PL97335160A patent/PL335160A1/en unknown
- 1997-11-26 JP JP10522997A patent/JP2000510156A/en active Pending
- 1997-11-26 HU HU9904092A patent/HUP9904092A3/en unknown
- 1997-11-26 IL IL12935197A patent/IL129351A0/en unknown
-
1999
- 1999-04-09 NO NO991701A patent/NO991701L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL335160A1 (en) | 2000-04-10 |
| CZ124999A3 (en) | 1999-09-15 |
| CO5070657A1 (en) | 2001-08-28 |
| AR009968A1 (en) | 2000-05-17 |
| NO991701L (en) | 2000-01-17 |
| AU7402998A (en) | 1998-12-08 |
| CA2268848A1 (en) | 1998-11-19 |
| ZA979095B (en) | 1998-05-11 |
| JP2000510156A (en) | 2000-08-08 |
| HUP9904092A3 (en) | 2000-07-28 |
| WO1998051303A1 (en) | 1998-11-19 |
| KR20000049064A (en) | 2000-07-25 |
| BR9712981A (en) | 2000-04-18 |
| NO991701D0 (en) | 1999-04-09 |
| PE11499A1 (en) | 1999-03-01 |
| EP0954309A1 (en) | 1999-11-10 |
| HUP9904092A2 (en) | 2000-04-28 |
| TR199901530T2 (en) | 1999-10-21 |
| SK46999A3 (en) | 2000-05-16 |
| CN1254281A (en) | 2000-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA979096B (en) | Viral and cancer treatment | |
| IL129351A0 (en) | Hiv and cancer treatment | |
| EG24678A (en) | Combination therapy | |
| AU7718898A (en) | Txu-7-pap immunotoxin and use thereof | |
| HU9602965D0 (en) | Cancer treatment and metastasis prevention | |
| IL127306A0 (en) | Combination therapy | |
| GB9700899D0 (en) | Novel treatment | |
| GB9700939D0 (en) | Therapy | |
| AU2418499A (en) | Org-5222 in the treatment of depression | |
| GB9303210D0 (en) | Cancer treatment | |
| GB9712761D0 (en) | Quinolines and their therapeutic use | |
| GB9703633D0 (en) | Cancer therapy | |
| EP0998578A4 (en) | Sel-10 AND USES THEREOF | |
| AU5871898A (en) | Microparticles and their use in cancer treatment | |
| GB9712869D0 (en) | Hair treatment | |
| GB9708380D0 (en) | HIV treatment | |
| GB9701117D0 (en) | HIV Treatment | |
| GB9721692D0 (en) | Novel treatment | |
| AU6409598A (en) | An improvement in the treatment of wastes | |
| GB9716742D0 (en) | Treatment | |
| GB9707104D0 (en) | An improvement in the treatment of bio-waste | |
| GB9424578D0 (en) | Cancer treatment | |
| GB9716289D0 (en) | Tumour treatment | |
| GB9605476D0 (en) | HIV gene therapy | |
| IL120901A0 (en) | Cancer therapy |